FDA approves first postpartum depression pill

The Food and Drug Administration approved the drug, called Zurzuvae, for adults experiencing severe depression related to childbirth or pregnancy. It's taken once a day for 14 days.

FDA approves first pill to treat postpartum depression - Top Class Actions

FDA Approves First Pill to Treat Postpartum Depression

FDA approves first postpartum depression pill

FDA approves first postpartum depression pill

Postpartum depression pill approved by FDA

5 things to know about 1st-ever FDA-approved pill for postpartum depression - ABC News

FDA approves Sage, Biogen drug for postpartum depression, but

FDA Approves First Pill for Postpartum Depression - Sharecare

How Virginians will benefit from postpartum depression pill

Curious Bioethics: July 31-August 6, 2023

FDA OKs First Pill for Postpartum Depression

FDA approves first postpartum depression pill in the US

FDA approves first pill to treat postpartum depression - Indiana Daily Student

FDA Approves First Oral Treatment for Postpartum Depression - US FDA